Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The trial currently has almost 10,000 patients enrolled and is expected to assess a composite MACE endpoint consisting of cardiovascular (CV) death, non-fatal myocardial infarction, or non-fatal stroke in patients with T2D as is expected to readout in July 2024 (NCT03574597)
Prentoe, J
To qualify for the Medicare GLP-1 Bridge program, according to the CMS website, a beneficiary must: Have prescription drug coverage under Medicare, known as Medicare Part D Be at least 18 Have a certain BMI, or body mass index, a measure of height and weight Be requesting the drug for weight loss in combination with lifestyle modifications including structured nutrition and physical activity Depending on a person's BMI, certain conditions like pre-diabetes, high blood pressure, chronic kidney disease and more may also be considered, USA Today reports
Weight Loss Weight Loss No prior prescription needed One-time provider review fee per order for new prescriptions No hidden costs, ever Ships same day in plain, discreet packaging If not approved, cost of medication automatically refunded HSA/FSA Eligible starting at $1,499.00 Web-form is not active
US$ 26.50
US$ 28.80
US$ 26.65
US$ 29.71
US$ 23.91
